Technology area: Biotechnology & Pharmaceuticals
10 pending office actions • 9 art units • 10 examiners • 0 of 10 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
The Boots Company PLC has 11 pending office actions in Biotechnology & Pharmaceuticals. The record identifies 11 distinct examiners and 9 distinct art units, showing that the portfolio is distributed across numerous examiner assignments and several technical groups.
PRAGANI, RAJAN is the busiest examiner, with 1 pending matter. No examiner has a listed concentration above that level, so docket oversight should prioritize consistency across independent prosecution channels rather than a single recurring examiner relationship.
The art-unit count is lower than the examiner count, which indicates that some technical groups contain matters handled by different examiners. That structure supports unit-level comparison of claim language and prior-art issues, but each response should still address its assigned examiner’s positions.
A coordinated review of recurring disclosure and claim themes can help reduce inconsistent arguments across the pending matters. The broad examiner distribution also makes clear docket ownership and response tracking particularly important.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 5 (50%) |
| §103 only | 2 (20%) |
| §112 only | 1 (10%) |
| Multi-statute (no §101) | 2 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BECKHARDT, LYNDSEY MARIE | 1 | 27.8% | +48.0% |
| PRAGANI, RAJAN | 1 | 52.4% | +71.4% |
| PIPIC, ALMA | 1 | 54.8% | +54.3% |
| BARHAM, BETHANY P | 1 | 51.8% | +32.2% |
| SAEED, ALI S | 1 | 31.6% | +33.8% |
| AFREMOVA, VERA | 1 | 50.5% | +29.4% |
| MI, QIUWEN | 1 | 68.4% | +50.0% |
| LIEB, JEANETTE M | 1 | 79.8% | +17.4% |
| BANERJEE, KOYELI | 1 | 33.3% | +0.0% |
| BOWLES, DAVID PAUL | 1 | 69.6% | +28.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18839511 | KIT OF COSMETIC COMPOSITIONS | BECKHARDT, LYNDSEY MARIE | — |
| 18839487 | COSMETIC COMPOSITION COMPRISING EXTRACT OF OPHIOPOGON JAPONICUS AND AT LEAST ONE CERAMIDE | PRAGANI, RAJAN | — |
| 18839080 | Antioxidant Compositions | SAEED, ALI S | — |
| 18839065 | Antioxidant Compositions | AFREMOVA, VERA | — |
| 18839084 | Antioxidant Compositions | MI, QIUWEN | — |
| 18687112 | COMPOSITION WITH BIOLOGICALLY ACTIVE AGENT | LIEB, JEANETTE M | — |
| 18686955 | COSMETIC COMPOSITIONS | BANERJEE, KOYELI | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18037447 | TETRAPEPTIDE AND COMPOSITIONS COMPRISING TETRAPEPTIDES | BOWLES, DAVID PAUL | 73d overdue |
| 18839511 | KIT OF COSMETIC COMPOSITIONS | BECKHARDT, LYNDSEY MARIE | — |
| 18839487 | COSMETIC COMPOSITION COMPRISING EXTRACT OF OPHIOPOGON JAPONICUS AND AT LEAST ONE CERAMIDE | PRAGANI, RAJAN | — |
| 18839529 | COSMETIC COMPOSITION CONTAINING RETINOID, EXTRACT OF CENTELLA ASIATICA AND A DIPEPTIDE | PIPIC, ALMA | — |
| 18839069 | Antioxidant Compositions | BARHAM, BETHANY P | — |
| 18839080 | Antioxidant Compositions | SAEED, ALI S | — |
| 18839065 | Antioxidant Compositions | AFREMOVA, VERA | — |
| 18839084 | Antioxidant Compositions | MI, QIUWEN | — |
| Art Unit | Apps |
|---|---|
| 1654 | 2 |
| 1613 | 1 |
| 1614 | 1 |
| 1617 | 1 |
| 1611 | 1 |
| 1615 | 1 |
| 1653 | 1 |
| 1655 | 1 |
| 1658 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18839511 | KIT OF COSMETIC COMPOSITIONS | BECKHARDT, LYNDSEY MARIE | 1613 | §102§103 | Non-Final OA | — | Pending | Aug 19, 2024 |
| 18839487 | COSMETIC COMPOSITION COMPRISING EXTRACT OF OPHIOPOGON JAPONICUS AND AT LEAST ONE CERAMIDE | PRAGANI, RAJAN | 1614 | §101§103§112DP | Non-Final OA | — | Pending | Aug 19, 2024 |
| 18839529 | COSMETIC COMPOSITION CONTAINING RETINOID, EXTRACT OF CENTELLA ASIATICA AND A DIPEPTIDE | PIPIC, ALMA | 1617 | §103 | Final Rejection | — | Pending | Aug 19, 2024 |
| 18839069 | Antioxidant Compositions | BARHAM, BETHANY P | 1611 | §103 | Non-Final OA | — | Pending | Aug 16, 2024 |
| 18839080 | Antioxidant Compositions | SAEED, ALI S | 1615 | §101§103§112DP | Non-Final OA | — | Pending | Aug 16, 2024 |
| 18839065 | Antioxidant Compositions | AFREMOVA, VERA | 1653 | §101§102§103 | Non-Final OA | — | Pending | Aug 16, 2024 |
| 18839084 | Antioxidant Compositions | MI, QIUWEN | 1655 | §101§102§103 | Non-Final OA | — | Pending | Aug 16, 2024 |
| 18687112 | COMPOSITION WITH BIOLOGICALLY ACTIVE AGENT | LIEB, JEANETTE M | 1654 | §102§112 | Non-Final OA | — | Pending | Feb 27, 2024 |
| 18686955 | COSMETIC COMPOSITIONS | BANERJEE, KOYELI | 1658 | §101§103§112 | Non-Final OA | — | Pending | Feb 27, 2024 |
| 18037447 | TETRAPEPTIDE AND COMPOSITIONS COMPRISING TETRAPEPTIDES | BOWLES, DAVID PAUL | 1654 | §112Other | Final Rejection | 73d overdue | Pending | May 17, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialThe Boots Company PLC has 10 pending office actions as of October 2026, spread across 9 art units and 10 examiners.
Lyndsey Marie Beckhardt has the most, with 1 of The Boots Company PLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
